Beschreibung:
<jats:title>Abstract</jats:title><jats:p>MDM2 is an oncoprotein that blocks p53 tumor suppressor-mediated transcriptional transactivation, escorts p53 from the cell nucleus to the cytoplasm, and polyubiquitylates p53. Polyubiquitylated p53 is rapidly degraded in the cytoplasm by the 26S proteasome. MDM2 is abnormally upregulated in several types of cancers, especially those of mesenchymal origin. MDM4 is a homolog of MDM2 that also inhibits p53 by blocking p53-mediated transactivation. MDM4 is required for MDM2-mediated polyubiquitylated of p53 and is abnormally upregulated in several cancer types. <jats:italic>MDM2</jats:italic> and <jats:italic>MDM4</jats:italic> genes have been detected in all vertebrates to date and only a single gene homolog, named <jats:italic>MDM</jats:italic>, has been detected in some invertebrates. <jats:italic>MDM2</jats:italic>, <jats:italic>MDM4,</jats:italic> and <jats:italic>MDM</jats:italic> have similar gene structures, suggesting that <jats:italic>MDM2</jats:italic> and <jats:italic>MDM4</jats:italic> arose through a duplication event more than 440 million years ago. All members of this small <jats:italic>MDM2</jats:italic> gene family contain a single really interesting new gene (RING) domain (with the possible exception of lancelet MDM) which places them in the RING-domain superfamily. Similar to MDM2, the vast majority of proteins with RING domains are E3 ubiquitin ligases. Other RING domain E3 ubiquitin ligases that target p53 are COP1, Pirh2, and MSL2. In this report, we present evidence that COP1, Pirh2, and MSL2 evolved independently of MDM2 and MDM4. We also show, through structure homology models of invertebrate MDM RING domains, that MDM2 is more evolutionarily conserved than MDM4.</jats:p>